EUVIMEDEUVIMED entdecken
Crossref

Neurokinin 3 receptor antagonism for menopausal hot flashes

Alexander N Comninos, Waljit S Dhillo

Cell · 2023-08 · 186 (16) · 3332-3332.e1

DOI: 10.1016/j.cell.2023.07.011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2023-08. Verfasst von Alexander N Comninos und 1 weiteren Autor:innen. Beteiligte Einrichtung: Section of Endocrinology & Investigative Medicine, Imperial College London, London, UK; Department of Endocrinology, Imperial College Healthcare NHS …. Hauptthemen laut MEDLINE: Hot Flashes, Menopause, Receptors, Neurokinin-3, Thiadiazoles. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: Medical Research Council, Department of Health, National Institute for Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Menopausal hot flashes are common and debilitating. Menopausal Hormone Therapy (MHT) is effective for hot flashes but has risks and side effects that limit its use. NK3 receptor antagonism has emerged as a novel therapeutic strategy, leading to the recent FDA approval of fezolinetant, a first-in-class nonhormonal treatment for menopausal hot flashes. To view this Bench to Bedside, open or download the PDF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hot FlashesMenopauseReceptors, Neurokinin-3ThiadiazolesHumansHeterocyclic Compounds, 2-RingFemale

Substanzen

Receptors, Neurokinin-3ThiadiazolesfezolinetantHeterocyclic Compounds, 2-Ring

Autor:innen und Institutionen

  • Section of Endocrinology & Investigative Medicine, Imperial College London, London, UK; Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK.
  • Section of Endocrinology & Investigative Medicine, Imperial College London, London, UK; Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK. Electronic address: w.dhillo@imperial.ac.uk.

Förderung

  • Medical Research Council
  • Department of Health
  • National Institute for Health Research

Zitieren

APA

Comninos, A. N., & Dhillo, W. S. (2023). Neurokinin 3 receptor antagonism for menopausal hot flashes. Cell, 186(16), 3332-3332.e1. https://doi.org/10.1016/j.cell.2023.07.011

Vancouver

Comninos AN, Dhillo WS. Neurokinin 3 receptor antagonism for menopausal hot flashes. Cell. 2023;186(16):3332-3332.e1. doi:10.1016/j.cell.2023.07.011

BibTeX
@article{Comninos2023,
  author = {Comninos, Alexander N and Dhillo, Waljit S},
  title = {Neurokinin 3 receptor antagonism for menopausal hot flashes},
  journal = {Cell},
  year = {2023},
  volume = {186},
  number = {16},
  pages = {3332--3332.e1},
  doi = {10.1016/j.cell.2023.07.011}
}
Kostenlos starten →